SCALISE: "THIS IS A MISTRIAL" Who will tell the

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
121
Quote:
SCALISE: "THIS IS A MISTRIAL"

Who will tell the gentleman from Louisiana, self described as David Duke without the baggage, that the trial has yet to begin?

“It's clear [Speaker] Pelosi needs to declare a mistrial.”


Scalise is a lying, hyperbolic, RW ass-clown who only appeals to same.

History shows Democrats are being fair to Republicans on Trump impeachment: Ex-Starr aide

https://www.usatoday.com/story/opinion/2019/1...099840002/

Paul Rosenzweig, Opinion contributorPublished 5:00 a.m. ET Oct. 31, 2019 | Updated 12:23 p.m. ET Oct. 31, 2019

This partisan vote is a sad commentary on the degradation of a once noble party. Republicans need to stop carping about process and face reality.

We stand on the cusp of history. Only three times in the past have impeachment proceedings against an American president begun. Twice, with Andrew Johnson and Bill Clinton, they resulted in impeachment and acquittal in the Senate. Richard Nixon resigned before articles of impeachment were voted on. And, now, we have President Donald Trump.

The House of Representatives process so far, and the plan it outlines going forward in a resolution it approved 232-196 on Thursday, have been subject to much complaint by the Republican members of Congress.

Yet the truth is that the process the Democrats have proposed is roughly analogous to the Clinton impeachment run by Republicans.


In both inquiries, the majority controlled the process of subpoena issuance; in both inquiries the normal rules of rapid-fire five-minute questioning by members were relaxed to allow for lengthier examination; and in both inquiries there are mechanisms by which the president could offer rebuttal evidence.

House is primary Trump investigator

The similarities are actually quite odd because the origins of the two impeachment proceedings are so different. Clinton’s was piggy-backed on top of a long-running, existing criminal investigation (one in which, full disclosure, I took part as a senior counsel to the Whitewater independent counsel Kenneth Starr).

Thus, the examination of Clinton’s interactions with his intern, Monica Lewinsky, initially took place behind closed doors, in the context of a grand jury investigation.


Given the thoroughness of the Starr investigation, the Republicans on the House Judiciary Committee ultimately determined not to take any new evidence. They did not, for example, hear directly from Ms. Lewinsky and based their impeachment decision principally on the report from and testimony of Starr, who functioned as a summary witness.

The contrast with current events could not be starker. The House is now examining President Trump’s efforts to hold military aid and a White House meeting for Ukraine hostage, in exchange for investigations of Joe and Hunter Biden and a theory that Ukraine interfered in the 2016 election.

There is no preexisting investigation; the House is the primary investigator. It is hearing from witnesses directly, and 47 Republican members of Congress sit on the committees conducting the inquiry.

Johnson impeachment expert: Trump lawyer pounds the table in lieu of arguing law or facts

While the current series of depositions is occurring in a classified setting, the House resolution makes clear that if the House eventually proceeds to a vote on impeachment, it will do so only after a public airing of the evidence before the Judiciary Committee.

And so the Democrats' process is much more reminiscent of the Nixon Watergate inquiry, which lasted for months, than of the abbreviated House consideration of Clinton’s conduct.

The procedural resolution passed with near-unanimous Democratic support and unanimous Republican opposition. But that is a political calculation, not a fair evaluation of the process.

Republican complaints ring hollow

Indeed, this partisan vote is a sad commentary on the degradation of a once noble party, of which I used to be a member. Any fair reading of history suggests that Republican complaints today ring hollow.

Advice from ex-Sen. Russ Feingold: As a Democrat, I took the Clinton impeachment seriously. Justice should top politics.

They contend, for example, that the Democrats' proposal violates due process. Yet that argument has a makeweight quality to it, given that the plan is a close cognate of the Clinton procedures; the Constitution says the House and Senate have "sole power" over their impeachment responsibilities; and a federal judge ruled just last week that the House impeachment proceeding was legal.

In as much as the Republicans were earlier complaining of the lack of any process at all, their current complaints only validate the Democratic charge that Republicans are moving the goal posts of their process demands in a never-ending series of retrenchments.

In the end then, the true measure of the fairness of the process lies not in the complaints of the Republican Party, but rather in an objective assessment of precisely what the Democrats have proposed.

And by that measure, they have done a reasonable job. If Republicans are reduced to complaining about process instead of facing the substantive reality of what has happened, they seem likely to only further hasten the erosion of their credibility.

Paul Rosenzweig, a senior fellow in the National Security and Cyber Security Program at the R Street Institute, was senior counsel to Kenneth Starr in the Whitewater investigation and a deputy assistant secretary of Homeland Security in the George W. Bush administration. Follow him on Twitter: @RosenzweigP
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BYD's Chip Mastery Amid China's Auto Supply Tensions

Updated Category News Views 2

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 7

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
ISO 45010: First Guidance for Menstruation, Menopause

Updated Category News Views 2

Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 3

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
Hyundai and UEFA: Kicking Off a Game-Changing Deal

Updated Category News Views 3

Hyundai Drives Into Europe's Football Arena Football fever just turned electric with Hyundai allying itself with the UEFA Champions League. We're not talking about sidelines. We're smack dab in the center field of a multi-year partnership starting with the 2026/27 season. Folks, if you think this is just Hyundai shaking hands for brand exposure, think again. This is...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 4

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026

Updated Category News Views 3

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Continue Reading

Top 5 Most Recently Viewed Articles

LogicGate Revolutionizes GRC Processes with Advanced AI Tools

Updated Category News Views 189

Empowering GRC Professionals with Innovative AI Solutions LogicGate is paving the way for Governance, Risk, and Compliance (GRC) professionals through its latest introduction of AI-driven features within the Risk Cloud Spark AI suite. These enhancements include the AI Text Assistant and Record Linking Recommendations capabilities, designed to optimize productivity and...

Continue Reading
Empowering SMBs with MarketTrends AI's Innovative Platform

Updated Category News Views 118

Introduction to MarketTrends AI MarketTrends AI has unveiled an innovative market intelligence platform tailored specifically for small and medium-sized businesses. This groundbreaking tool empowers businesses to navigate through market changes, analyze customer behaviors, and address competitive challenges with unprecedented efficiency and effectiveness. Customizable...

Continue Reading
Enhancing Efficiency in Healthcare Contracts with Icertis

Updated Category News Views 313

AIDS Healthcare Foundation Implements Icertis for Improved Contract Management In today's dynamic healthcare environment, having streamlined contract management is crucial for organizations aiming to enhance efficiency and profitability. The AIDS Healthcare Foundation (AHF) has recently partnered with Icertis, a leader in AI-powered contract intelligence, to transform its...

Continue Reading
New World Development Faces Challenges Amid Property Decline

Updated Category News Views 123

New World Development Faces Major Share Decline New World Development Co. has seen its shares drop by as much as 14%, reflecting the struggles of the billionaire Cheng family's firm amid a challenging property downturn. This decline mirrors the wider issues that developers in Hong Kong are grappling with due to economic pressures. Expected Financial Loss Recently, the...

Continue Reading
Join the Investigation into MoonLake Immunotherapeutics Claims

Updated Category News Views 211

Investigation into MoonLake Immunotherapeutics The Schall Law Firm, recognized for its commitment to shareholder rights, is currently investigating potential claims against MoonLake Immunotherapeutics (NASDAQ: MLTX). This investigation centers on whether the company misled investors and failed to disclose vital information regarding its operations and trial results....

Continue Reading